Press Releases

Email Alerts

Mar 13, 2018

Biostage Preclinical Study Results Published in New Report

Large-animal study results published in Nature Scientific Reports show successful esophageal regeneration

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat conditions of the esophagus, bronchus and trachea, today announced the publication of...
Feb 20, 2018

Biostage Closes $1 Million Private Placement

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat conditions of the esophagus, bronchus and trachea, today announced the previously disclosed...
Feb 12, 2018

Biostage Appoints to its Scientific Advisory Board Charles S. Cox, Jr., MD

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat conditions of the esophagus, bronchus and trachea, today announced the appointment of Charles...
- Photos 1
Feb 7, 2018

Biostage, Inc. Names Jason Chen Chairman of its Board of Directors

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced that it...
- Photos 1
Feb 6, 2018

Biostage to Host Conference Call to Provide Business Update

- Conference Call with Live Audio Webcast on Tuesday, February 13th at 9:00 AM ET -

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced that on...

Show per page